1. Epidemiology, Management, and Outcome of Invasive Fungal Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation in China: A Multicenter Prospective Observational Study 
Yuqian Sun, Fanyi Meng, Mingzhe Han, Xi Zhang, Li Yu, He Huang, Depei Wu, Hanyun Ren, Chun Wang, Zhixiang Shen, Yu Ji, Xiaojun Huang 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 6, Pages (June 2015)
DOI: /j.bbmt
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidence of invasive fungal disease (IFD) in recipients of transplants from (A) different donor types and (B) different sources of stem cell 187 days after hematopoietic stem cell transplantation (n = 1387; the 14 IFDs that occurred before transplantation were excluded from this analysis).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Overall survival in (A) patients who received allogeneic hematopoietic stem cell transplantation (HSCT) or autologous HSCT; (B) patients with proven/probable invasive fungal disease (IFD), possible IFD, suspected IFD and receiving antifungal therapy, no suspected IFD and not receiving antifungal therapy, or any IFD (proven, probable, or possible).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions